Accordingly, it was logical to surmise that functional genetic variants in RhoA and ROCK1 were likely to result in different activity of RhoA/ROCK1 and affect functions of PCa cells, which led to BCR in PCa patients. The gene discussed is ROCK1; the disease is posterior cortical atrophy.